No Prescription |
 |
 | ||
|
Metformin Generic Glucophage |
|
| ||
No Prescription » Prescription Drugs 10 » Metformin Generic Glucophage ARROW - METFORMIN Tablets are used to control blood glucose in patients with diabetes mellitus.There are two types of diabetes mellitus:type 1 also called insulin dependent diabetes mellitus type 2 also called non-insulin dependent diabetes mellitus or maturity onset diabetes. People with type 2 diabetes are unable to make enough insulin or their body does not respond properly to the insulin it does make. This causes a build up of glucose in the blood which can lead to serious medical problems.ARROW - METFORMIN is used when diet and exercise are not enough to control your blood glucose levels. ARROW - METFORMIN can be used alone or in combination with other medicines for treating diabetes.ARROW - METFORMIN can also be used in patients with type 1 diabetes mellitus where insulin alone is not enough to control blood glucose levels.ARROW - METFORMIN is not recommended for use in children except for those with insulin resistant diabetes who are being treated in hospital.Your doctor may however prescribe ARROW - METFORMIN for another reason. Ask your doctor if you have any questions about why ARROW - METFORMIN has been prescribed for you.There is no evidence that ARROW - METFORMIN is addictive. Buy Metformin Generic Glucophage and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Metformin Generic Glucophage: Product Type: Prescription Drugs 10 Metformin ( Generic Glucophage ) Metformin (Generic Glucophage) Generic Glucophage 500mg 2 x 500Tablets 500mg 4 x 500Tablets 500mg 500 Tablets 850mg 250 Tablets 850mg 2 x 250 Tablets 850mg 4 x 250 Tablets Generic Glucophage Metformin
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
